Genexine and KGbio received the first market approval for novel long-acting Erythropoietin, Efepoetin alfa, from The Indonesian Food and Drug Authority (BPOM)
SEOUL, South Korea--(BUSINESS WIRE)--Oct 23, 2023--
Source: eagletribune.com
Fast, Ad-Free News Updates
Stay updated with breaking news from Nutritional Division. Real-time updates on events, politics, business and more.